Sandbox/AIRSG

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]

Aortic Regurgitation Resident Survival Guide Microchapters
Overview
Causes
FIRE
Complete
Acute
Chronic
Treatment
Acute
Chronic
Do's
Don'ts

Overview

Aortic regurgitation (AR) refers to the retrograde or backward flow of blood from the aorta into the left ventricle during diastole.[1][2][3][4] The presentation depends on the response and adaptability of the left ventricle to the increased diastolic volume, in chronic AR the left ventricle has adapted by dilatation of its walls. However, in acute AR, a rapid increase in the diastolic volume is not tolerated by a normal size ventricle and this could lead to cardiogenic shock. The most common causes of acute aortic regurgitation are aortic dissection and infective endocarditis and the preferred treatment in both cases surgical intervention. The most common cause of chronic AR is bicuspid aortic valve and the treatment will depend on the stage of the disease. Acute AR is a life-threatening condition and must be recognized and treated promptly.

Causes

Life Threatening Causes

Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.

Common Causes

Click here for the complete list of causes.

FIRE: Focused Initial Rapid Evaluation

A Focused Initial Rapid Evaluation (FIRE) should be performed to identify patients in need of immediate intervention. The algorithm below is based on the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease.[6][7]

Boxes in salmon signify that an urgent management is needed.

 
 
 
 
 
 
 
 
 
 
Identify cardinal findings that increase the pretest probability of acute aortic regurgitation

❑ ❑
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Does the patient have any of the following findings that require urgent management?

Tachycardia
Hypotension
Loss of consciousness
Tachypnea

 
 
 
 
 
 
 
 
 

Diagnosis

A complete diagnostic approach should be carried out after a focused initial rapid evaluation is conducted and following initiation of any urgent intervention.[6][7]

Abbreviations: BP: blood pressure; CXR: chest X-ray; ECG: electrocardiogram; LV: left ventricle; MI: myocardial infarction; TTE: Transthoracic echocardiography; TEE: Transesophageal echocardiography

Acute Aortic Regurgitation

 
 
 
 
Characterize the symptoms:

❑ Sudden and severe dyspnea
Palpitations

Symptoms suggestive of aortic dissection
Chest pain

❑ Sudden onset
❑ Intense
❑ Tearing and sharp
❑ Interscapular
❑ Worsened by deep breathing or cough
❑ Relieved by sitting upright

Syncope

Symptoms suggestive of infective endocarditis
❑ Fever
Sweats
Fatigue
Pleuritic chest pain

Back pain
Weakness
Myalgias
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Inquire about past medical history:
Cardiac disease:
Hypertension
Bicuspid aortic valve

Rheumatic fever
Marfan syndrome
Connective tissue disorder
Prosthetic valves
Intravenous drug use

❑ Substances used in the mixture
❑ Sharing the equipment
❑ The process of cleaning the equipment
❑ Previous infective endocarditis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Examine the patient:

Vitals
Temperature

Fever (suggestive of infective endocarditis)

Heart rate:

Tachycardia

Blood pressure:

❑ Systolic BP differential > 20 mmHg
Hypertension (suggestive of ]]aortic dissection]])

Cardiovascular examination
❑ Pulses

❑ Weak

Cardiac auscultation

Murmur
❑ Low pitched early diastolic murmur (may be absent)
❑ Best heard at the right 2nd intercostal space in aortic dissection
Heart sounds
❑ Decreased or absent S1
❑ Increased P2 (suggestive of pulmonary hypertension)
S3 may be present

Respiratory examination
Rales (suggestive of pulmonary congestion)

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Order tests:

TTE (most important evaluation test) (Class I; Level of Evidence: B)

In high suspicion of aortic dissection, perform a TEE

Chest X-ray

❑ Increase cardiac silhouette (suggestive of aortic dissection)
Widened mediastinum (suggestive of aortic root dilation)
❑ Pulmonary congestion (suggestive of pulmonary hypertension)

ECG

❑ Nonspecific changes of ST and T wave (due to LV enlargement)
Right coronary artery ischemic changes (suggestive of aortic dissection)
ST elevation in II, III, aVF (Inferior MI)
ST elevation in V1R and V4R (Right ventricle MI)
ST depression in V1-V3 (Posterior MI)

Blood culture (if suspected infective endocarditis)

Cardiac enzymes (Troponin, CK-MB)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Determine the etiology of the aortic regurgitation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 


Chest pain of the following characteristics:
❑ Sudden onset
❑ Intense
❑ Tearing and sharp
❑ Interscapular
❑ Worsened by deep breathing or cough
❑ Relieved by sitting upright

Syncope
❑ Low pitched early diastolic murmur

❑ Best heard at the right 2nd intercostal space

❑ Previous history of:

Marfan syndrome
Connective tissue disorder
 


❑ Persistent fever
❑ New valvular regurgitation murmur
❑ Bacteremia
❑ Vegetations found on TTE
❑ High risk factors:
❑ Pre-existing cardiac abnormality
❑ Prosthetic valve
❑ Recent surgical or medical procedures
❑ Intravenous drug use
❑ Recent bacterial infection
❑ History of previous endocarditis
❑ Evaluate the modified Duke criteria (click here to see the modified Duke criteria)
 
Other causes


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Treat the underlying cause of acute aortic regurgitation
 


Chronic Aortic Regurgitation

 
 
 
 
 
 
Characterize the symptoms:
Dyspnea on exertion
Orthopnea
Paroxysmal nocturnal dyspnea
Palpitations
Chest pain
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Inquire about past medical history:
Cardiac disease:
Hypertension
Bicuspid aortic valve
Rheumatic fever
Pulmonary disease
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Examine the patient:

Vitals
Heart rate:

Tachycardia (suggestive of reduced stroke volume)

Blood pressure:

Wide pulse pressure (≥ 60 mmHg)

Cardiovascular examination
❑ Pulses

Corrigan's pulse: a rapid upstroke and collapse of the carotid artery pulse

Cardiac auscultation

Murmur
❑ Early diastolic decrescendo murmur
❑ Best heard at the upper left sternal border
❑ Murmur increases with sitting forward, expiration and handgrip
Austin Flint murmur: a soft mid-diastolic rumble, best heard at the cardiac apex
Heart sounds
S3 may be present (suggestive of left ventricular dysfunction)

❑ Search for other signs suggestive of aortic regurgitation

Traube's sign: systolic and diastolic murmurs described as 'pistol shots' heard over the femoral artery when it is gradually compressed
Müller's sign: systolic pulsations of uvula [8]
de Musset's sign: head bobbing with each heart beat
Hill's sign: ≥ 20 mmHg difference in popliteal and brachial systolic cuff pressures (suggestive of chronic severe AR)
Quincke's sign: pulsation of the capillary bed in the nail

Respiratory examination

Rales (seen when congestive heart failure has developed)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Order imaging studies:

TTE (most important evaluation test) (Class I; Level of Evidence: B)

Assess the following:
❑ Valve morphology
❑ Pressure gradient
❑ Aortic valve area
❑ Ejection fraction
❑ LV wall thickness and motility

Chest X-ray

❑ Increase cardiac silhouette (suggestive of aortic dissection)
Widened mediastinum (suggestive of aortic root dilation)
❑ Pulmonary congestion (suggestive of HF)

ECG

❑ Nonspecific changes of ST and T wave (due to LV enlargement)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Classify aortic regurgitation based on the following findings on TTE:
❑ Vena contracta
❑ Jet/LVOT
❑ Regurgitant volume
❑ Regurgitant fraction
❑ Effective regurgitant orifice
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Risk of AI (Stage A)

❑ No regurgitation
 
Mild (Stage B)

❑ Vena contracta <0.3 cm
❑ Jet/LVOT <25%
❑ Regurgitant volume <30 mL/beat
❑ Regurgitant fraction <30%
❑ Effective regurgitant orifice <0.10 cm²
 
Moderate (Stage B)

❑ Vena contracta 0.3-0.6 cm
❑ Jet/LVOT 25-64%
❑ Regurgitant volume 30-59 mL/beat
❑ Regurgitant fraction 30-49%
❑ Effective regurgitant orifice 0.10-0.29 cm²
 
Severe

❑ Vena contracta >0.6 cm
❑ Jet/LVOT ≥ 65%
❑ Regurgitant volume ≥60 mL/beat
❑ Regurgitant fraction ≥50%
❑ Effective regurgitant orifice ≥ 0.30 cm²
❑ Holodiastolic flow reversal in the proximal abdominal aorta
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Asymptomatic

Stage C1
❑ Normal LVEF
❑ Mild to moderate dilatation
Stage C2
LV systolic dysfunction
❑ Decreased LVEF or severe LV dilatation
 
Symptomatic (Stage D)

❑ Normal or decreased LV systolic function
❑ Moderate to severe LV dilatation
 
 
 
 
 

Treatment

Acute Aortic Regurgitation

Shown below is an algorithm for the treatment of acute aortic regurgitation according to the 2014 AHA/ACC Guidelines for the Management of Valvular Heart Disease.[1][2][3][4]

 
 
 
 
 
 
 
 
Determine the etiology
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mild or moderate regurgitation
(Stage B)
 
 
Severe regurgitation
(Stage C or D)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Perform elective surgery in 6 weeks if:
❑ Fungal infection, or
❑ Resistant bacterial infection ,or
❑ Large vegetation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

❑ The use of nitroprusside and inotropic agents (such as: dopamine and dobutamine) help reduce the LV end-diastolic pressure before surgery
Avoid the use of beta blockers because may block compensating tachycardia

Urgent surgical intervention
❑ Aortic valve replacement
Intra-aortic balloon counterpulsation is contraindicated

Chronic Aortic Regurgitation

Shown below is an algorithm summarizing the treatment approach to chronic aortic regurgitation according to the 2014 AHA/ACC Guidelines on the Management of Valvular Heart Disease.[1][2][3][4]


 
 
 
 
Interpret results from TTE
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
No regurgitation
(Stage A)
 
Progressive regurgitation (Stage B)
Mild
❑ Vena contracta <0.3 cm
❑ Jet/LVOT <25%
❑ Regurgitant volume <30 mL/beat
❑ Regurgitant fraction <30%
❑ Effective regurgitant orifice <0.10 cm²
Moderate
❑ Vena contracta 0.3-0.6 cm
❑ Jet/LVOT 25-64%
❑ Regurgitant volume 30-59 mL/beat
❑ Regurgitant fraction 30-49%
❑ Effective regurgitant orifice 0.10-0.29 cm²
 
 
 
 
 
Severe regurgitation

❑ Vena contracta >0.6 cm
❑ Jet/LVOT ≥ 65%
❑ Regurgitant volume ≥60 mL/beat
❑ Regurgitant fraction ≥50%
❑ Effective regurgitant orifice ≥ 0.30 cm²
❑ Holodiastolic flow reversal in the proximal abdominal aorta
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Asymptomatic patients
❑ Normal valve
Bicuspid valve
Sclerotic valve
 
Asymptomatic patients
Control hypertension (Class I; Level of Evidence: B)
 
 
 
Asymptomatic
(Stage C)
 
 
 
 
Symptomatic
(Stage D)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Perform a periodic echocardiogram (Class I; Level of Evidence:B)
❑ Every 3 -5 years for mild regurgitation
❑ Every 1 - 2 years for moderate regurgitation
 

❑ Normal LVEF
❑ Mild to moderate dilatation
 
 

LV systolic dysfunction
❑ Decreased LVEF
❑ Severe LV dilatation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Perform a periodic echocardiogram every 6 - 12 months (Class I; Level of Evidence: B)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
If patient undergoes another cardiac surgery:
Schedule for AVR (Class IIa; Level of Evidence: C)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Choice of Intervention

Shown below is an algorithm summarizing the choice of the intervention to aortic stenosis based on the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease [6]

 
 
 
 
 
 
Patient scheduled for AVR
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
High risk
 
 
 
 
 
Low to moderate risk
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
❑ A multidisciplinary group should decide intervention (Surgical AVR or TAVR) (Class I; Level of Evidence: C)
❑ Schedule for TAVR (Class IIa; Level of Evidence: B)[6] [9]
 
 
 
 
 
❑ Schedule for surgical AVR (Class I; Level of Evidence: A)
 
 
 
 

Do's


Don'ts

❑ Do not use beta blockers in AI of causes other than AD as it will block the compensation tachycardia. ❑ Do not use intra-aortic baloon counterpulsation in severe acute AI as it will increase the aortic diastolic pressure and the regurgitant volume.

References

  1. 1.0 1.1 1.2 Connolly HM, Crary JL, McGoon MD; et al. (1997). "Valvular heart disease associated with fenfluramine-phentermine". N. Engl. J. Med. 337 (9): 581–8. doi:10.1056/NEJM199708283370901. PMID 9271479.
  2. 2.0 2.1 2.2 Weissman NJ (2001). "Appetite suppressants and valvular heart disease". Am. J. Med. Sci. 321 (4): 285–91. doi:10.1097/00000441-200104000-00008. PMID 11307869.
  3. 3.0 3.1 3.2 Schade R, Andersohn F, Suissa S, Haverkamp W, Garbe E (2007). "Dopamine agonists and the risk of cardiac-valve regurgitation". N. Engl. J. Med. 356 (1): 29–38. doi:10.1056/NEJMoa062222. PMID 17202453.
  4. 4.0 4.1 4.2 Zanettini R, Antonini A, Gatto G, Gentile R, Tesei S, Pezzoli G (2007). "Valvular heart disease and the use of dopamine agonists for Parkinson's disease". N. Engl. J. Med. 356 (1): 39–46. doi:10.1056/NEJMoa054830. PMID 17202454.
  5. Nishimura, RA. (2002). "Cardiology patient pages. Aortic valve disease". Circulation. 106 (7): 770–2. PMID 12176943. Unknown parameter |month= ignored (help)
  6. 6.0 6.1 6.2 6.3 Nishimura, R. A.; Otto, C. M.; Bonow, R. O.; Carabello, B. A.; Erwin, J. P.; Guyton, R. A.; O'Gara, P. T.; Ruiz, C. E.; Skubas, N. J.; Sorajja, P.; Sundt, T. M.; Thomas, J. D. (2014). "2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines". Circulation. doi:10.1161/CIR.0000000000000031. ISSN 0009-7322.
  7. 7.0 7.1 Bonow, R. O.; Carabello, B. A.; Chatterjee, K.; de Leon, A. C.; Faxon, D. P.; Freed, M. D.; Gaasch, W. H.; Lytle, B. W.; Nishimura, R. A.; O'Gara, P. T.; O'Rourke, R. A.; Otto, C. M.; Shah, P. M.; Shanewise, J. S. (2008). "2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". Circulation. 118 (15): e523–e661. doi:10.1161/CIRCULATIONAHA.108.190748. ISSN 0009-7322.
  8. Williams BR, Steinberg JP (2006). "Images in clinical medicine. Müller's sign". The New England Journal of Medicine. 355 (3): e3. doi:10.1056/NEJMicm050642. PMID 16855259. Retrieved 2012-04-15. Unknown parameter |month= ignored (help)
  9. Smith, Craig R.; Leon, Martin B.; Mack, Michael J.; Miller, D. Craig; Moses, Jeffrey W.; Svensson, Lars G.; Tuzcu, E. Murat; Webb, John G.; Fontana, Gregory P.; Makkar, Raj R.; Williams, Mathew; Dewey, Todd; Kapadia, Samir; Babaliaros, Vasilis; Thourani, Vinod H.; Corso, Paul; Pichard, Augusto D.; Bavaria, Joseph E.; Herrmann, Howard C.; Akin, Jodi J.; Anderson, William N.; Wang, Duolao; Pocock, Stuart J. (2011). "Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients". New England Journal of Medicine. 364 (23): 2187–2198. doi:10.1056/NEJMoa1103510. ISSN 0028-4793.


Template:WikiDoc Sources